Price (delayed)
$495.69
Market cap
$53.52B
P/E Ratio
11.87
Dividend/share
$1.76
EPS
$41.77
Enterprise value
$53.13B
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities , it
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.